Products

Services

Applications

Company

Resources

Contact

Applications
Applications
Telomeres, the protective caps at the end of our chromosomes, sit at the intersection of aging, cancer, and neurodegeneration research.
Telomeres, the protective caps at the end of our chromosomes, sit at the intersection of aging.
Research & Translation
Biopharma Research
Clinical Development

Products
Products
Explore our advanced sequencing products for turning complex molecular signals into high-confidence readouts across clinical testing, RNA quality control, and translational methylation programs.
NeuroLens®
Neuron Cell-Death Test
RNA Clarity™
RNA Vaccine QC
MethylMap™
Native-Read Methylation Sequencing

Services
Services
End-to-end sequencing services supporting genomic, epigenomic, and transcriptomic analysis, from experimental design and assay development to bioinformatics, interpretation, and data delivery.
Native-Read Multiomic Sequencing
Direct Whole Methylome Sequencing (gDNA)
Direct Methylation Sequencing (cfDNA)
Direct Targeted Methylation Sequencing (gDNA)
Whole Genome Sequencing
RNA Sequencing
Direct RNA Sequencing
cDNA Sequencing
Specialized Services
Telomere Sequencing
Proteomics (available soon)

Applications
Applications
Explore how our products and services help solve difficult biological and genomic problems, from liquid biopsy signals to complex regions and emerging biomarker development.
Hard-to-Sequence Genes & Complex Regions
Liquid Biopsy cfDNA Analysis
Custom Multiomic Panel Development

Company
Company
Building the future of precision diagnostics through sequencing innovation, scientific rigor, and collaborative partnerships.
About Us
Team

A Scalable Alternative to Methylation Arrays

MethylMap

™

Healthcare worker wearing mask and gloves adjusting an IV drip in a hospital room.

MethylMap is Renew Biotechnologies' nanopore-based platform for scalable whole-methylome profiling.

By combining shallow whole-genome native methylation sequencing, proprietary library preparation, and array-compatible analytical workflows, MethylMap enables high-throughput epigenetic profiling.

MethylMap captures native DNA methylation without bisulfite conversion or PCR amplification, supporting genome-wide biomarker discovery, epigenome-wide association studies, and population-scale research.

MethylMap Supports Whole-Methylome Discovery and Large-Scale Cohort Analysis

Whole-Methylome Discovery

Generate Genome-Wide Epigenetic Insights Beyond Fixed Array Content

Regional Methylation Analysis

Characterize methylation patterns across genomic regions.

Integrated Genetic and Epigenetic Analysis

Link sequence variation with native methylation patterns.

Novel Biomarker Discovery

Discover methylation signatures linked to biological phenotypes.

Large-Scale Cohort Analysis

Enable High-Throughput Epigenetic Profiling Across Research Populations

Epigenome-Wide Association Studies

Identify methylation associations across large research cohorts.

Cohort Stratification

Identify molecularly distinct subgroups within study populations.

Large Population Studies

Scale methylome profiling across high-throughput cohorts.

MethylMap Differentiation

Key Advantages

Broader, genome-wide methylation coverage beyond predefined probe targets

Native methylation (5mc, 5hmc, 6ma) without bisulfite-associated damage or PCR-related bias

Array-compatible analysis workflows for QC, summarization, and differential methylation

Platform Architecture / Workflow

Proprietary gDNA library preparation

5x nanopore sequencing

.CH3 methylation file generation

ModSeqR analysis and visualization

Array-compatible analysis workflows

General Discovery

Where structural variation and methylation jointly shape tumor biology, native long-read sequencing provides critical resolution. Many cancers involve large rearrangements and epigenetic changes that are difficult to profile with short-read or array-based approaches alone.

To demonstrate this approach in oncology, whole-genome MethylMap data from ovarian, lung, and lymphoma tumor samples were evaluated for methylation coverage and variant detection. Even at low coverages, MethylMap supported methylation profiling and detection of large variants, highlighting its potential for scalable oncology research.

Bar chart showing percent unique CpG sites covered at sequencing depths 5x, 10x, 15x, and 30x dWMS.

Figure 1. MethylMap maintains genome-wide CpG coverage across sequencing depths. Bar plots show CpG coverage at ≥1x, ≥5x, ≥10x, and ≥15x across 5x, 10x, 15x, and 30x genomic coverage. Pooled ovarian, lung, and lymphoma tumor (n = 3). Even at 5x coverage, all unique CpGs were covered at least once, supporting scalable methylation profiling from discovery to regional analysis.

Tissue of Origin

Tissue- and cell-of-origin studies use methylation patterns to infer the source of circulating DNA, supporting liquid biopsy and biomarker development. Traditional approaches can miss informative regional patterns when tissue-specific signals fall outside fixed array content or are reduced by bisulfite-related damage.

MethylMap provides broader native methylation context across tissue-informative regions, enabling more detailed tissue-of-origin estimation for translational studies and circulating DNA applications.

Genomic visualization showing gene MAP3K2-DT with methylation patterns across two tissues and gene annotations.

Figure 2. MethylMap expands CpG resolution for tissue-of-origin analysis. Across a representative 15 kb region, MethylMap detected ~15x more CpG sites than the EPIC methylation array while maintaining concordance at overlapping loci. Each ONT track represents a single read, with red indicating methylated CpGs and blue indicating unmethylated CpGs.

Download Case Study

Explore MethylMap for Your Research Program

Apply MethylMap to epigenome-wide association studies, biomarker discovery, and population-scale research. Contact us to discuss pilot projects, study design, and bioinformatics support